Quantcast

Latest Spinal muscular atrophy Stories

2013-07-09 23:27:38

Scientist from preclinical CRO, PharmOptima, presents new assay at the 2013 International SMA Research Group Meeting. Portage, MI (PRWEB) July 09, 2013 "Spinal Muscular Atrophy (SMA) is a motor neuron disease. The motor neurons affect the voluntary muscles that are used for activities such as crawling, walking, head and neck control, and swallowing. It is a relatively common "rare disorder": approximately 1 in 6000 babies born are affected, and about 1 in 40 people are...

2013-06-06 23:01:33

Stories of Hope, Success and Progress Illustrate Need for Collaboration With Patients Horsham, Pa. (PRWEB) June 06, 2013 Utah Assistant Attorney General and spinal muscular atrophy survivor Steve Mikita and five other inspiring patient advocates will share stories of their tireless efforts to insert the patient voice at each step of the drug development process at the DIA 2013 49th Annual Meeting in Boston this month. The news media are invited to listen to the compelling stories of these...

2013-05-15 23:04:54

StorageMart pledged to donate $1 for every pin in March and April of their "Pin for a Cure" image resulting in a $5,000 donation to the MDA. Columbia, MO (PRWEB) May 15, 2013 Surrounded by beakers, lab tables, and microscopes, StorageMart President, Cris Burnam met with Dr. Lorson, PhD. and Patti Butera, MDA Area Manager, to present the results of StorageMart´s “Pin for a Cure” Pinterest campaign. StorageMart pledged to donate up to $5,000 each time the Pin for A Cure...

2013-05-07 23:22:26

This program will assess the therapeutic potential of second-generation Antisense Oligonucleotides (ASO) sequences for SMA. This funding is being awarded to Co-Principal Investigators Dr. Arthur Burghes at Ohio State University and Dr. Christian Lorson at University of Missouri. Elk Grove Village, IL (PRWEB) May 07, 2013 Families of SMA is dedicated to creating a treatment and cure for Spinal Muscular Atrophy (SMA) by funding and advancing a comprehensive research program, including drug...

2013-04-10 11:35:03

ALS drug effects highlights potassium channel role There is no specific drug to treat spinal muscular atrophy (SMA), a family of motor neuron diseases that in its most severe form is the leading genetic cause of infant death in the United States and affects one in 6,000 people overall. But a new multispecies study involving a drug that treats amyotrophic lateral sclerosis (ALS) has pinpointed a mechanism of SMA that drug developers might be able to exploit for a new therapy. The...

2013-03-18 10:56:41

The following research from Columbia University Medical Center and NewYork-Presbyterian Hospital is being presented at the 65th annual meeting of the American Academy of Neurology (AAN), March 16-23, 2013, in San Diego. For additional information, or to arrange an interview, please contact Karin Eskenazi at 212-342-0508 or ket2116@columbia.edu, or Christina Stolfo at 212-305-5587 or chs9135@nyp.org ORAL PRESENTATIONS Deoxypyrimidine Monophosphates Treatment for Thymidine Kinase 2...


Word of the Day
barghest
  • A goblin in English folklore, often appearing in the shape of a large dog and believed to portend imminent death or misfortune.
  • A ghost, wraith, hobgoblin, elf, or spirit.
The origin of 'barghest' is not known, but it may be from perhaps burh-ghest, town-ghost, or German Berg-geist (mountain spirit) or Bär-geist (bear-spirit).
Related